Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Long-Term Investments (2024 - 2025)

Historic Long-Term Investments for Dianthus Therapeutics (DNTH) over the last 2 years, with Q3 2025 value amounting to $152.9 million.

  • Dianthus Therapeutics' Long-Term Investments rose 14864.84% to $152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.9 million, marking a year-over-year increase of 14864.84%. This contributed to the annual value of $81.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Dianthus Therapeutics' Long-Term Investments is $152.9 million, which was up 14864.84% from $51.7 million recorded in Q2 2025.
  • Dianthus Therapeutics' 5-year Long-Term Investments high stood at $152.9 million for Q3 2025, and its period low was $51.7 million during Q2 2025.